Hasil Pencarian - Ranjan Chrisanthar

  • Menampilkan 1 - 2 hasil dari 2
Perbaiki Hasil
  1. 1
    CHEK2 mutations affecting kinase activity together with mutations in TP53 indicate a functional pathway associated with resistance to epirubicin in primary breast cancer.

    CHEK2 mutations affecting kinase activity together with mutations in TP53 indicate a functional pathway associated with resistance to epirubicin in primary breast cancer. oleh Ranjan Chrisanthar, Stian Knappskog, Erik Løkkevik, Gun Anker, Bjørn Østenstad, Steinar Lundgren, Elisabet O Berge, Terje Risberg, Ingvil Mjaaland, Lovise Maehle, Lars Fredrik Engebretsen, Johan Richard Lillehaug, Per Eystein Lønning

    Diterbitkan 2008-01-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  2. 2
    Predictive and prognostic impact of TP53 mutations and MDM2 promoter genotype in primary breast cancer patients treated with epirubicin or paclitaxel.

    Predictive and prognostic impact of TP53 mutations and MDM2 promoter genotype in primary breast cancer patients treated with epirubicin or paclitaxel. oleh Ranjan Chrisanthar, Stian Knappskog, Erik Løkkevik, Gun Anker, Bjørn Ostenstad, Steinar Lundgren, Terje Risberg, Ingvil Mjaaland, Gudbrand Skjønsberg, Turid Aas, Ellen Schlichting, Hans E Fjösne, Arne Nysted, Johan Richard Lillehaug, Per Eystein Lønning

    Diterbitkan 2011-04-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:

Alat Pencarian: